Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 CellsOmar Prado-Carrillo(Instituto Nacional de Cancerología), Patricia García‐López(Instituto Nacional de Cancerología)International Journal of Molecular SciencesJuly 12, 202210.3390/ijms23147715Cited by 17SaveCiteExport RISWatch citationsRelated PapersLiposomes Co-Encapsulating Cisplatin/Mifepristone Improve the Effect on Cervical Cancer: In Vitro and In Vivo Assessment|Pharmaceutics|2020|36Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide|Frontiers in Oncology|2020|25